Safety and immunogenicity of a recombinant tandem-repeat dimeric RBD-based protein subunit vaccine (ZF2001) against COVID-19 in adults: two randomised, double-blind, placebo-controlled, phase 1 and 2 trials

Yang, SL; Li, Y; Dai, LP; Wang, JF; He, P; Li, CG; Fang, X; Wang, CF; Zhao, X; Huang, EQ; Wu, CW; Zhong, ZX; Wang, FZ; Duan, XM; Tian, SY; Wu, LL; Liu, Y; Luo, Y; Chen, ZH; Li, FJ; Li, JH; Yu, X; Ren, H; Liu, LH; Meng, SF; Yan, JH; Hu, ZY; Gao, LD; Gao, GF

Gao, GF (corresponding author), Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing 10010, Peoples R China.; Gao, LD (corresponding author), Hunan Prov Ctr Dis Control & Prevent, Changsha 410005, Peoples R China.

LANCET INFECTIOUS DISEASES, 2021; 21 (8): 1107

Abstract

Background Although several COVID-19 vaccines have been developed so far, they will not be sufficient to meet the global demand. Development of a wide......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索